Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
PLoS One
    January 2024
  1. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    >> Share

  2. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    >> Share

  3. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    >> Share

  4. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    >> Share

  5. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

  6. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    >> Share

  7. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    >> Share

  8. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    >> Share

  9. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    >> Share

  10. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    >> Share

  11. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    >> Share

  12. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    >> Share

    January 2023
  13. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    >> Share

  14. GRANJA DOMINGUEZ A, Romero Sevilla R, Aleman A, Duran C, et al
    Study for the validation of the FeetMe(R) integrated sensor insole system compared to GAITRite(R) system to assess gait characteristics in patients with multiple sclerosis.
    PLoS One. 2023;18:e0272596.
    >> Share

  15. HARARI G, Gurevich M, Dolev M, Zilkha Falb R, et al
    Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study.
    PLoS One. 2023;18:e0280515.
    >> Share

  16. BARAK-CORREN Y, Castro VM, Javitt S, Nock MK, et al
    Improving risk prediction for target subpopulations: Predicting suicidal behaviors among multiple sclerosis patients.
    PLoS One. 2023;18:e0277483.
    >> Share

  17. SOKRATOUS D, Charalambous CC, Papanicolaou EZ, Michailidou K, et al
    Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
    PLoS One. 2023;18:e0272114.
    >> Share

  18. ERSOY T, Hocaoglu E
    A 3-DoF robotic platform for the rehabilitation and assessment of reaction time and balance skills of MS patients.
    PLoS One. 2023;18:e0280505.
    >> Share

  19. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    >> Share

  20. LAICHINGER K, Bombach P, Dunschede J, Ruschil C, et al
    No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.
    PLoS One. 2023;18:e0283476.
    >> Share

  21. ZAFEIRI L, Akerfeldt T, Tolf A, Carlson K, et al
    Anti-Mullerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    PLoS One. 2023;18:e0284288.
    >> Share

  22. BENINI S, Pellegrini E, Descovich C, Lugaresi A, et al
    Burden and resources in caregivers of people with multiple sclerosis: A qualitative study.
    PLoS One. 2023;18:e0265297.
    >> Share

  23. STAHL D, Friberg E
    Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.
    PLoS One. 2023;18:e0286010.
    >> Share

  24. EVEREST E, Uygunoglu U, Tutuncu M, Bulbul A, et al
    Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
    PLoS One. 2023;18:e0287463.
    >> Share

  25. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    PLoS One. 2023;18:e0285599.
    >> Share

  26. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    >> Share

  27. VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
    Evaluation of multiple sclerosis severity using a new OCT tool.
    PLoS One. 2023;18:e0288581.
    >> Share

  28. NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
    Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
    PLoS One. 2023;18:e0288319.
    >> Share

  29. FRAGKIADAKI E, Cotterill N, Rice C, Smith JA, et al
    Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol.
    PLoS One. 2023;18:e0288295.
    >> Share

  30. RAZIA R, Majeed F, Amin R, Mukhtar S, et al
    Predictive value of alpha-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
    PLoS One. 2023;18:e0285022.
    >> Share

  31. MACHADO A, Azad A, Pettersson E, Hillert J, et al
    Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references.
    PLoS One. 2023;18:e0288998.
    >> Share

  32. MEIJBOOM R, York EN, Kampaite A, Harris MA, et al
    Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    PLoS One. 2023;18:e0288967.
    >> Share

  33. HERNANDEZ M, Ramon-Julvez U, Vilades E, Cordon B, et al
    Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography.
    PLoS One. 2023;18:e0289495.
    >> Share

  34. HARRIS VK, Wollowitz J, Greenwald J, Carlson AL, et al
    Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis.
    PLoS One. 2023;18:e0290069.
    >> Share

  35. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    >> Share

  36. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Correction: Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2023;18:e0293225.
    >> Share

  37. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    >> Share

  38. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    >> Share

  39. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    >> Share

    January 2022
  40. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    >> Share

  41. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    >> Share

  42. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    >> Share

  43. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    >> Share

  44. CHOI S, Spini M, Hua J, Harrison DM, et al
    Correction: Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2022;17:e0264452.
    >> Share

  45. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    >> Share

  46. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    >> Share

  47. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    >> Share

  48. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    >> Share

  49. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    >> Share

  50. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    >> Share

  51. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    >> Share

  52. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    >> Share

  53. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    >> Share

  54. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    >> Share

  55. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    >> Share

  56. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    >> Share

  57. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    >> Share

  58. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    >> Share

  59. RASKIN E, Achiron A, Zloto O, Neuman R, et al
    Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
    PLoS One. 2022;17:e0264918.
    >> Share

  60. PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
    IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
    PLoS One. 2022;17:e0270607.
    >> Share

  61. KRAUSE A, Lee K, Konig D, Faist M, et al
    Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
    PLoS One. 2022;17:e0270698.
    >> Share

  62. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    >> Share

  63. VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
    Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0272156.
    >> Share

  64. TU H, Li N, Liu W, Fan Z, et al
    Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0269371.
    >> Share

  65. ABUAF AF, Bunting SR, Klein S, Carroll T, et al
    Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
    PLoS One. 2022;17:e0274778.
    >> Share

  66. KUENDIG S, Kool J, Polhemus A, Schallert W, et al
    Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability.
    PLoS One. 2022;17:e0274348.
    >> Share

  67. NING L, Wang B
    Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0274565.
    >> Share

  68. YANG B, Parker RB, Meibohm B, Temrikar ZH, et al
    Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis.
    PLoS One. 2022;17:e0278111.
    >> Share

  69. VALORI M, Lehikoinen J, Jansson L, Clancy J, et al
    High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls.
    PLoS One. 2022;17:e0278245.
    >> Share

  70. CLARKSON TC, Iguchi N, Xie AX, Malykhina AP, et al
    Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus.
    PLoS One. 2022;17:e0278918.
    >> Share

  71. AL-KAFAJI G, Alwehaidah MS, Alsabbagh MM, Alharbi MA, et al
    Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis.
    PLoS One. 2022;17:e0279237.
    >> Share

  72. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2022;17:e0270875.
    >> Share

  73. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
    PLoS One. 2022;17:e0279132.
    >> Share

    January 2021
  74. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    >> Share

  75. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    >> Share

  76. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    >> Share

  77. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    >> Share

  78. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    >> Share

  79. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    >> Share

  80. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    >> Share

  81. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    >> Share

  82. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    >> Share

  83. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    >> Share

  84. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    >> Share

  85. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    >> Share

  86. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    >> Share

  87. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    >> Share

  88. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    >> Share

  89. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    >> Share

  90. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    >> Share

  91. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    >> Share

  92. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    >> Share

  93. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    >> Share

  94. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    >> Share

  95. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    >> Share

    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    >> Share

  97. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    >> Share

  98. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    >> Share

  99. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    >> Share

  100. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    >> Share

  101. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    >> Share

  102. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    >> Share

  103. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    >> Share

  104. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    >> Share

  105. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    >> Share

    January 2020
  106. ALNAJASHI H, Jabbad R
    Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
    PLoS One. 2020;15:e0241103.
    >> Share

  107. COTTRELL L, Economos G, Evans C, Silber E, et al
    A realist review of advance care planning for people with multiple sclerosis and their families.
    PLoS One. 2020;15:e0240815.
    >> Share

  108. MELNIKOV M, Sharanova S, Sviridova A, Rogovskii V, et al
    The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    PLoS One. 2020;15:e0240305.
    >> Share

  109. PERLEJEWSKI K, Bukowska-Osko I, Rydzanicz M, Dzieciatkowski T, et al
    Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.
    PLoS One. 2020;15:e0240601.
    >> Share

  110. ZHANG X, Gao B, Xu B
    No association between the vitamin D-binding protein (DBP) gene polymorphisms (rs7041 and rs4588) and multiple sclerosis and type 1 diabetes mellitus: A meta-analysis.
    PLoS One. 2020;15:e0242256.
    >> Share

  111. BEREK K, Hegen H, Auer M, Zinganell A, et al
    Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi.
    PLoS One. 2020;15:e0239453.
    >> Share

  112. NIKOLIC B, Ivancevic N, Zaletel I, Rovcanin B, et al
    Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
    PLoS One. 2020;15:e0243031.
    >> Share

  113. CORDON B, Vilades E, Orduna E, Satue M, et al
    Angiography with optical coherence tomography as a biomarker in multiple sclerosis.
    PLoS One. 2020;15:e0243236.
    >> Share

  114. VICKARYOUS N, Jitlal M, Jacobs BM, Middleton R, et al
    Remote testing of vitamin D levels across the UK MS population-A case control study.
    PLoS One. 2020;15:e0241459.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016